I ran 16:8 for 14 months straight. Glucose variability dropped, I lost 11 pounds in the first 10 weeks, and my morning HRV climbed from 54 to 61. I was evangelical. I tracked everything. Then, around month 9, the weight crept back. Not all of it, but enough to make me ask the question I should have asked earlier: what does the long-term data actually say?

The honest answer is: almost nothing. Harvard's nutrition researchers put it plainly, noting that most trials run 12 months or less. The clinical picture for IF beyond that window is close to blank. The 3-8% body weight loss over 3-24 weeks is real and reproducible. The 4-7% loss with 16:8 over 12-16 weeks is real. But those numbers come from trials that end right when the interesting question starts: what happens after the honeymoon?

The Lipid Problem Nobody Wants to Talk About

A 2026 meta-analysis across 32 studies found that water-only fasting raised LDL with an effect size of 0.489 and dropped HDL after roughly 3 days of fasting. That is not a rounding error. The cardiovascular story IF advocates have been selling, that fasting is a heart-health protocol, just got significantly more complicated. I am not saying IF causes heart disease. I am saying the lipid data is moving in a direction that should make any serious optimizer pause before treating this as a permanent stack.

The adherence numbers are genuinely good: 70-80% at 3 months versus 60-70% for traditional calorie restriction. That edge is real and meaningful for people who find meal timing easier to manage than portion counting. Krista Varady's March 2026 PCOS study showed improved hormone levels with 80% of participants planning to continue, which is a legitimate win for a specific population. The mechanism matters there: time-restricted eating appears to reduce insulin resistance in ways that benefit PCOS specifically.

Dr. Alex Chen would say I am cherry-picking the lipid data while ignoring that calorie restriction produces the same weight outcomes with the same long-term uncertainty. Fair point. But calorie restriction has decades of population data behind it. IF is asking for the same credibility with a fraction of the evidence trail.

What I Actually Recommend Now

IF is a useful entry ramp, not a destination. The 16:8 window works well for people who naturally skip breakfast or eat late, because it converts an existing habit into a caloric deficit without requiring them to count anything. That is high ROI for low friction. But treating it as a permanent metabolic protocol, the way I did for 14 months, is getting ahead of the science.

My current position: run IF for 8-12 weeks as a reset tool. Track your LDL before and after. If it moves up meaningfully, that is a signal worth taking seriously. Then shift to a structure with more long-term evidence behind it, Mediterranean eating patterns, protein-forward calorie restriction, whatever your adherence data supports. The goal is a sustainable caloric architecture, not loyalty to a feeding window.

The optimization community, myself included for a long time, treated IF like a discovered truth rather than a promising hypothesis. The short-term results are real. The long-term evidence is not there yet. Those are two different things, and conflating them is how you end up defending a protocol your own biomarkers are quietly arguing against.